{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:23:13Z","timestamp":1792498993174,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Respiratory tract infections (RTIs) are one of the leading causes of morbidity and mortality worldwide. The increase in antimicrobial resistance in respiratory pathogens poses a major challenge to the effective management of these infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To investigate the distribution of major pathogens of RTIs and their antimicrobial resistance patterns in a tertiary care hospital and to develop a mathematical model to explore the relationship between pathogen distribution and antimicrobial resistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Five hundred patients with RTIs were included in the study and 475 bacterial strains were isolated from their respiratory specimens. Antimicrobial susceptibility testing and analysis of influencing factors were performed. A mathematical model was developed to simulate the relationship between pathogen distribution and drug resistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The most common pathogens were Streptococcus pneumoniae (30%), Haemophilus influenzae (20%), Pseudomonas aeruginosa (15%), Staphylococcus aureus (10%) and Klebsiella pneumoniae (10%). The distribution of pathogens varied according to age group and type of RTIs, with higher proportions of Pseudomonas aeruginosa and Staphylococcus aureus in hospital-acquired and ventilator-associated pneumonia. Isolated pathogens showed high and increasing rates of resistance to commonly used antibiotics. Model simulations suggest that a shift in the distribution of pathogens toward more resistant strains may lead to a significant increase in overall resistance rates, even if antibiotic use patterns remain unchanged.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study emphasizes the importance of regular monitoring of respiratory pathogen distribution and antimicrobial resistance patterns and the need for a comprehensive approach to managing RTIs, including implementation of antibiotic stewardship programs, infection control measures, and development of new therapies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-10549-7","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:11:48Z","timestamp":1738159908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Modeling and simulation of distribution and drug resistance of major pathogens in patients with respiratory system infections"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"10100","key":"10549_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"regional Global","year":"2017","unstructured":"Global regional. National incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet. 2017;390(10100):1211\u201359.","journal-title":"Lancet"},{"issue":"1","key":"10549_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/thx.2009.129502","volume":"67","author":"T Welte","year":"2012","unstructured":"Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71\u20139.","journal-title":"Thorax"},{"key":"10549_CR3","unstructured":"Antimicrobial Resistance Global Report on Surveillance. Geneva: World Health Organization; 2014."},{"issue":"4","key":"10549_CR4","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277\u201383.","journal-title":"P T"},{"issue":"1","key":"10549_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrmicro1325","volume":"4","author":"EY Furuya","year":"2006","unstructured":"Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol. 2006;4(1):36\u201345.","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10549_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0169-5347(97)01223-8","volume":"12","author":"F Baquero","year":"1997","unstructured":"Baquero F, Bl\u00e1zquez J. Evolution of antibiotic resistance. Trends Ecol Evol. 1997;12(12):482\u20137.","journal-title":"Trends Ecol Evol"},{"issue":"1","key":"10549_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2047-2994-2-31","volume":"2","author":"A Huttner","year":"2013","unstructured":"Huttner A, Harbarth S, Carlet J, et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated infections Forum. Antimicrob Resist Infect Control. 2013;2(1):31.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"Suppl 2","key":"10549_CR8","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27\u201372.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10549_CR9","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated Pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61\u2013111.","journal-title":"Clin Infect Dis"},{"key":"10549_CR10","volume-title":"Manual of Clinical Microbiology","author":"KC Carroll","year":"2019","unstructured":"Carroll KC, Pfaller MA. Manual of Clinical Microbiology. 12th ed. Washington, DC: ASM; 2019.","edition":"12"},{"issue":"Suppl 4","key":"10549_CR11","doi-asserted-by":"publisher","first-page":"S296","DOI":"10.1093\/cid\/cir045","volume":"52","author":"JG Bartlett","year":"2011","unstructured":"Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011;52(Suppl 4):S296\u2013304.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10549_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/QCO.0b013e32835ebc6d","volume":"26","author":"MI Restrepo","year":"2013","unstructured":"Restrepo MI, Faverio P, Anzueto A. Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26(2):151\u20138.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10549_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SYC Tong","year":"2015","unstructured":"Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603\u201361.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10549_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/2049-632X.12033","volume":"67","author":"SL Gellatly","year":"2013","unstructured":"Gellatly SL, Hancock REW. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013;67(3):159\u201373.","journal-title":"Pathog Dis"},{"issue":"4","key":"10549_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cid\/cit247","volume":"57","author":"R Patel","year":"2013","unstructured":"Patel R. Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. Clin Infect Dis. 2013;57(4):564\u201372.","journal-title":"Clin Infect Dis"},{"key":"10549_CR16","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020."},{"issue":"3","key":"10549_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10549_CR18","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/647952","volume":"49","author":"JH Jorgensen","year":"2009","unstructured":"Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749\u201355.","journal-title":"Clin Infect Dis"},{"key":"10549_CR19","unstructured":"IBM Corp. Released 2017. IBM SPSS statistics for Windows, Version 25.0. Armonk, NY: IBM Corp."},{"key":"10549_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer Jr","year":"2013","unstructured":"Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken, NJ: Wiley; 2013.","edition":"3"},{"issue":"4","key":"10549_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/thx.2010.143982","volume":"66","author":"C Cill\u00f3niz","year":"2011","unstructured":"Cill\u00f3niz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66(4):340\u20136.","journal-title":"Thorax"},{"issue":"6","key":"10549_CR22","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","volume":"128","author":"MH Kollef","year":"2005","unstructured":"Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854\u201362.","journal-title":"Chest"},{"issue":"3","key":"10549_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1378\/chest.07-1456","volume":"133","author":"MI Restrepo","year":"2008","unstructured":"Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133(3):610\u20137.","journal-title":"Chest"},{"issue":"17","key":"10549_CR24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMra1312885","volume":"371","author":"DM Musher","year":"2014","unstructured":"Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014;371(17):1619\u201328.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10549_CR25","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1086\/653053","volume":"51","author":"RN Jones","year":"2010","unstructured":"Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S81\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10549_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","volume":"78","author":"HS Sader","year":"2014","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009\u20132011). Diagn Microbiol Infect Dis. 2014;78(4):443\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10549_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"DM Sievert","year":"2013","unstructured":"Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010. Infect Control Hosp Epidemiol. 2013;34(1):1\u201314.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"16","key":"10549_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.1993.03510160083034","volume":"270","author":"MH Kollef","year":"1993","unstructured":"Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA. 1993;270(16):1965\u201370.","journal-title":"JAMA"},{"issue":"3","key":"10549_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cid\/cit734","volume":"58","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis. 2014;58(3):330\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10549_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1378\/chest.115.2.462","volume":"115","author":"MH Kollef","year":"1999","unstructured":"Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462\u201374.","journal-title":"Chest"},{"issue":"19","key":"10549_CR31","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588\u201398.","journal-title":"JAMA"},{"issue":"7","key":"10549_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10096-014-2067-1","volume":"33","author":"A Torres","year":"2014","unstructured":"Torres A, Blasi F, Peetermans WE, Viegi G, Welte T. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014;33(7):1065\u201379.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"RR\u201316","key":"10549_CR33","first-page":"1","volume":"51","author":"JM Boyce","year":"2002","unstructured":"Boyce JM, Pittet D. Guideline for Hand Hygiene in Health-Care settings. MMWR Recomm Rep. 2002;51(RR\u201316):1\u2013CE4. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC\/SHEA\/APIC\/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America\/Association for Professionals in Infection Control\/Infectious Diseases Society of America.","journal-title":"MMWR Recomm Rep"},{"issue":"9238","key":"10549_CR34","first-page":"1307","volume":"356","author":"D Pittet","year":"2000","unstructured":"Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infect Control Programme Lancet. 2000;356(9238):1307\u201312.","journal-title":"Infect Control Programme Lancet"},{"issue":"2","key":"10549_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/s-0029-1202941","volume":"30","author":"T Welte","year":"2009","unstructured":"Welte T, K\u00f6hnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med. 2009;30(2):127\u201335.","journal-title":"Semin Respir Crit Care Med"},{"issue":"9998","key":"10549_CR36","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","volume":"386","author":"E Prina","year":"2015","unstructured":"Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet. 2015;386(9998):1097\u2013108.","journal-title":"Lancet"},{"issue":"7","key":"10549_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/518460","volume":"28","author":"DJ Weber","year":"2007","unstructured":"Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol. 2007;28(7):825\u201331.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10549_CR38","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/338782","volume":"34","author":"DM Livermore","year":"2002","unstructured":"Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002;34(5):634\u201340.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10549_CR39","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1097\/CCM.0b013e3181a037ac","volume":"37","author":"D Koulenti","year":"2009","unstructured":"Koulenti D, Lisboa T, Brun-Buisson C, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med. 2009;37(8):2360\u20138.","journal-title":"Crit Care Med"},{"issue":"Suppl 5","key":"10549_CR40","doi-asserted-by":"publisher","first-page":"S378","DOI":"10.1086\/533594","volume":"46","author":"E Rubinstein","year":"2008","unstructured":"Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):S378\u201385.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10549_CR41","first-page":"473","volume":"13","author":"N Petrosillo","year":"2015","unstructured":"Petrosillo N, Cataldo MA, Pea F. Treatment options for community-acquired pneumonia in the elderly people. Expert Rev Anti Infect Ther. 2015;13(4):473\u201385.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"10","key":"10549_CR42","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1128\/AAC.00851-07","volume":"51","author":"ST Micek","year":"2007","unstructured":"Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007;51(10):3568\u201373.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10549_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1128\/CMR.00058-15","volume":"29","author":"L Kim","year":"2016","unstructured":"Kim L, McGee L, Tomczyk S, Beall B. Biological and Epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and Post-conjugate Vaccine eras: a United States Perspective. Clin Microbiol Rev. 2016;29(3):525\u201352.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10549_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/CMR.00040-06","volume":"20","author":"S Tristram","year":"2007","unstructured":"Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev. 2007;20(2):368\u201389.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10549_CR45","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1128\/AAC.48.12.4606-4610.2004","volume":"48","author":"MD Obritsch","year":"2004","unstructured":"Obritsch MD, Fish DN, MacLaren R, Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother. 2004;48(12):4606\u201310.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10549_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"10549_CR47","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1086\/320184","volume":"32","author":"DJ Diekema","year":"2001","unstructured":"Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997\u20131999. Clin Infect Dis. 2001;32(Suppl 2):S114\u201332.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10549_CR48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159\u201377.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10549_CR49","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1093\/cid\/cit578","volume":"57","author":"AM Caliendo","year":"2013","unstructured":"Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57(Suppl 3):S139\u201370.","journal-title":"Clin Infect Dis"},{"issue":"10 Suppl 2","key":"10549_CR50","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.ajic.2007.10.006","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165\u201393.","journal-title":"Am J Infect Control"},{"issue":"2","key":"10549_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","volume":"16","author":"L Czaplewski","year":"2016","unstructured":"Czaplewski L, Bax R, Clokie M, et al. Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis. 2016;16(2):239\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10549_CR52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/QCO.0b013e3283462362","volume":"24","author":"L Opatowski","year":"2011","unstructured":"Opatowski L, Guillemot D, Bo\u00eblle PY, Temime L. Contribution of mathematical modeling to the fight against bacterial antibiotic resistance. Curr Opin Infect Dis. 2011;24(3):279\u201387.","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10549_CR53","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/aje\/kwt017","volume":"178","author":"IH Spicknall","year":"2013","unstructured":"Spicknall IH, Foxman B, Marrs CF, Eisenberg JN. A modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization. Am J Epidemiol. 2013;178(4):508\u201320.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10549_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S0950268807009442","volume":"136","author":"L Temime","year":"2008","unstructured":"Temime L, Hejblum G, Setbon M, Valleron AJ. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study. Epidemiol Infect. 2008;136(3):289\u201398.","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10549_CR55","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/sim.5636","volume":"32","author":"M Aldrin","year":"2013","unstructured":"Aldrin M, Raastad R, Tvete IF, et al. Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment. Stat Med. 2013;32(8):1407\u201318.","journal-title":"Stat Med"},{"issue":"10","key":"10549_CR56","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1086\/323761","volume":"33","author":"MJ Bonten","year":"2001","unstructured":"Bonten MJ, Austin DJ, Lipsitch M. Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin Infect Dis. 2001;33(10):1739\u201346.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10549_CR57","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1093\/clinids\/24.Supplement_1.S9","volume":"24","author":"BR Levin","year":"1997","unstructured":"Levin BR, Lipsitch M, Perrot V, et al. The population genetics of antibiotic resistance. Clin Infect Dis. 1997;24(Suppl 1):S9\u201316.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10549-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10549-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10549-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:11:53Z","timestamp":1738159913000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10549-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10549"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10549-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Anting Hospital, Jiading District (approval date: May 1, 2023). The study was conducted in accordance with the principles of the Declaration of Helsinki. All study participants signed an informed consent form, and for participants under the age of consent, informed consent was obtained from their parents or legal guardians. The study protocol (version number: 1.0, version date: May 1, 2023) was approved after an expedited review process. The duties, composition, operation and records of the ethics committee were in accordance with the requirements of GCP, ICH-GCP and relevant Chinese regulations. Strict protection measures, including data encrypted storage and access rights control, were taken during data collection and use to ensure patient information security.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"138"}}